LES LABORATOIRES SERVIER

Company Overview

Servier Laboratories is a pharmaceutical company engaged in the R&D of reference products to treat various diseases, including cardiovascular diseases (such as coronary artery disease, hypertension and stroke), cancer, and diabetes. The company was founded in 1954. It has a presence in 140 countries, including the U.S., Australia, Canada, China, and the Russian Federation, with more than 21,800 employees and nearly 3,000 involved in R&D.

Cardiovascular drugs account for about two-thirds of the company’s annual revenues. Servier Laboratories produces medicines to treat diabetes, venous disease and cancer. Its pharmaceuticals can be found in 140 countries; 80% of its sales are generated internationally.

It produces drugs for clinical trials in cardiovascular disease, endocrinology, oncology, rheumatology, venous disease, ENT, and neurosciences, and its asthenia product portfolio; the company has a strategic alliance with Galapagos NV.